Treatment and prevention of bacterial infections during cytostatic chemotherapy.
D000380:Agranulocytosis / Q000150:complications*; D000583:Amikacin / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D001803:Blood Transfusion; D002228:Carbenicillin / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D004357:Drug Synergism; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D009503:Neutropenia / Q000150:complications*
D002511:Cephalosporins; D007612:Kanamycin; D000583:Amikacin; D002228:Carbenicillin